ArticleJHEP reports : innovation in hepatology2025

The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes.

Hiroaki Kanzaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.